Related Experiment Video
Updated: Jan 28, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through
Yuan Yuan1, Juan Wang2, Qiuxiang Chen3
1Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan 430060, China.
Insights
Long non-coding RNA CYTOR may protect against cardiac hypertrophy by regulating miR-155, IKKi, and NF-kB signaling. CYTOR acts as a ceRNA, counteracting miR-155
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Non-coding RNA Biology
Background:
- Pathological cardiac hypertrophy can lead to heart failure and sudden death.
- Previous studies linked IKKi deficiency to cardiac hypertrophy via AKT and NF-kB pathways.
- Non-coding RNAs, including lncRNAs and miRNAs, are critical in pathological processes.
Purpose of the Study:
- Identify upregulated long non-coding RNAs (lncRNAs) in cardiac hypertrophy.
- Investigate the role of lncRNA cytoskeleton regulator RNA (CYTOR) in cardiac hypertrophy.
- Elucidate the mechanism of CYTOR action, focusing on its interaction with miR-155 and IKBKE.
Main Methods:
- Microarray analysis of GEO database for lncRNA identification.
- Analysis of GTEx project data for CYTOR-IKBKE correlation.
- Experimental manipulation of CYTOR and miR-155 in mouse models and cardiomyocytes.
- Luciferase reporter and RNA immunoprecipitation (RIP) assays to confirm interactions.
Main Results:
- CYTOR was upregulated in cardiac hypertrophy and positively correlated with IKBKE.
- CYTOR knockdown exacerbated cardiac hypertrophy induced by aortic banding and Angiotensin II.
- CYTOR functions as a competing endogenous RNA (ceRNA) for miR-155, preventing miR-155-mediated repression of IKBKE.
- CYTOR knockdown decreased IKKi protein and activated NF-kB, effects partially rescued by miR-155 inhibition.
Conclusions:
- CYTOR plays a protective role in cardiac hypertrophy.
- The protective mechanism involves CYTOR acting as a ceRNA for miR-155 to regulate IKBKE and downstream NF-kB signaling.
- CYTOR represents a potential therapeutic target for managing cardiac hypertrophy.
Abstract:
Pathological cardiac hypertrophy, which may lead to heart failure and sudden death, can be affected by multiple factors. In our previous study, we revealed that IKKi deficiency induced cardiac hypertrophy through the activation of the AKT and NF-kB signaling pathway in response to aortic banding (AB). Non-coding RNAs, mainly long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), play a crucial role in normal developmental and pathological processes. In the present study, microarray analysis results from GEO database were analyzed, and upregulated lncRNAs in cardiac hypertrophy were identified. Of them, lncRNA cytoskeleton regulator RNA (CYTOR) obtained a fold-change of 6.16 and was positively correlated with IKBKE according to the data from The GTEx project. CYTOR knockdown significantly enhanced the inducible effect of AB operation on mice myocardial hypertrophy and Angiotensin II on cardiomyocyte hypertrophy. Moreover, miR-155 was significantly related to hypertrophic cardiomyopathy (HCM, |hsa05410) and predicted to target both CYTOR and IKBKE. Luciferase reporter and RIP assays revealed that CYTOR served as a ceRNA for miR-155 to counteract miR-155-mediated repression of IKBKE. Moreover, CYTOR knockdown reduced IKKi protein levels while activated NF-kB signaling pathway, whereas miR-155 inhibition exerted an opposing effect; the effect of CYTOR could be partially attenuated by miR-155 inhibition. Taken together, CYTOR might play a protective role in cardiac hypertrophy through miR-155 and downstream IKKi and NF-κB signaling, most possibly through serving as a ceRNA for miR-155 to counteract miR-155-mediated repression of IKBKE.
Related Concept Videos
RNA Splicing
RNA Polymerase II Accessory Proteins
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Structure
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...

